Real-World Case Insight: Triple FDC Therapy in a Young Diabetes Patient - Dr Naresh Kumar
Written By : Dr Naresh Kumar
Published On 2025-10-01 07:20 GMT | Update On 2025-10-03 06:23 GMT
Advertisement
In this video, Dr. Naresh Kumar, Consultant Diabetologist from Tamil Nadu, presents a real-world case of a 24-year-old male student with fatigue and polyuria, diagnosed with type 2 diabetes mellitus (T2DM) and cardiovascular (CV) risk.
The patient was initiated on a triple fixed-dose combination (FDC) of vildagliptin, dapagliflozin, and metformin, leading to rapid and sustained clinical improvements. Within just 4 weeks, fasting and postprandial blood glucose levels were effectively controlled. Over 6 months, HbA1c dropped significantly from 9.3% to 6.5%, reflecting excellent glycemic management. Notably, homocysteine levels normalized, reducing cardiovascular risk, while the patient reported marked improvement in energy levels, overall well-being, and quality of life.
This case underscores the value of early initiation of vildagliptin–dapagliflozin–metformin FDC in young patients with uncontrolled T2DM and elevated CV risk, highlighting its efficacy, safety, and potential to improve both metabolic and cardiovascular outcomes.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.